According to The Fly, hSBC analyst Steve McGarry maintained a Sell rating on AstraZeneca (AZN) today. The company’s shares opened today at $40.91, close to its 52-week high of $41.39.
According to TipRanks.com, McGarry is ranked #3514 out of 4900 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AstraZeneca with a $50 average price target.
See today’s analyst top recommended stocks >>
AstraZeneca’s market cap is currently $103.9B and has a P/E ratio of 38.38. The company has a Price to Book ratio of 8.20.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
